Extending these findings, our work specifically addresses inflammation-driven cardiac fibrosis, FAP.CAR-T uniquely eliminates activated myofibroblasts in autoimmune myocarditis, achieving fibrosis reduction and functional recovery (Figure 3-4). The gene discussed is FAP; the disease is autoimmune myocarditis.